The methyl-probes covered 60 glioma-tumor genes, 34 of which were involved in the cancer pathway and 20 genes participated in the process of Cell fate or TP53/MYC regulation signaling (Figure 1D and Supplementary Table S2). The gene discussed is MYC; the disease is neoplasm.